I really like this company. Having worked in cardiology and being acutely familiar with electrophysiology labs and their shortcomings, this company has the answer to poor ECG signal quality during ablation, and I can see a lot of demand for their device. FDA 501k expected in Q3.
NASDAQ uplist in March/April likely. One to watch!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.